Symbol: |
G0S2
|
Description: |
G0/G1switch 2 [Source:HGNC Symbol;Acc:30229]
|
Location: |
Chr1:209848765-209849733[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:147
Gene |
Compound |
Gen_sig |
Exp_pattern |
G0S2 |
VOBTUSINE, (3E)-HYDROXY- |
0.001 |
Down |
G0S2 |
CYTOVARICIN |
0.041 |
Up |
G0S2 |
NSC 351351 |
0.016 |
Down |
G0S2 |
CI-941 |
0.037 |
Down |
G0S2 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.02 |
Down |
G0S2 |
C.I. 37559 |
0.002 |
Down |
G0S2 |
Curromycin A.B mixture |
0.044 |
Up |
G0S2 |
RAPAMYCIN PRODRUG |
0.042 |
Down |
G0S2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.027 |
Down |
G0S2 |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.043 |
Down |
G0S2 |
Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- |
0.005 |
Up |
G0S2 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.019 |
Down |
G0S2 |
Naphthalene-1,2-dione, 1,2-dihydro- 4-[(2-phenylethyl)amino]- |
0.009 |
Up |
G0S2 |
3,8,13,18-Pentaazapentacosane pentahydrochloride |
0.007 |
Up |
G0S2 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.017 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:73
Total:5 Current:1
[First] [Prev]  Next Last 
|